Biochemical parameters | Reference values* | Before treatment | After treatment | p |
---|---|---|---|---|
TPa (g/L); n = 29 | 59–87 | 84.0 ± 15.6 | 72.9 ± 6.2 | < 0.001 |
ALBa (g/L); n = 29 | 31–47 | 23.6 ± 6.3 | 36.7 ± 3,6 | < 0.001 |
ALBa (%); n = 29 | 44.5–62.3 | 28.7 ± 8.9 | 50.6 ± 6.2 | < 0.001 |
GLOBa (g/L); n = 29 | 28.0–51.0 | 60.1 ± 16.2 | 36.3 ± 7.0 | < 0.001 |
GLOBa (%); n = 29 | 5.9–23 | 70.9 ± 9.6 | 49.4 ± 6.4 | < 0.001 |
A/Ga; n = 29 | > 0.57 | 0.433 ± 0.224 | 1.058 ± 0.265 | < 0.001 |
Alpha- 1 globulins (g/L); n = 7 | 1.6–5.2 | 1.8; 1.6–2.1 | 2.3; 2.0–2.5 | 0.176 |
Alpha- 2 globulins (g/L); n = 7 | 4.0–12.8 | 8.4; 6.1–11.1 | 5.5; 4.6–7.4 | 0.018 |
Beta- 1 globulins (g/L); n = 7 | 1.9–7.4 | 4.5; 3.8–5.1 | 5.2; 5.0–5.5 | 0.150 |
Beta- 2 globulins (g/L); n = 7 | 2.0–8.5 | 7.0; 5.8–8.1 | 6.1; 5.0–6.7 | 0.128 |
Gamma-globulins (g/L); n = 7 | 3.6–16.9 | 32.9; 19.0–47.6 | 12.7; 12.3–19.4 | 0.028 |
ALT(U/L); n = 28 | 27–110 | 39.0; 31.3–50.8 | 67.5; 50.0–80.0 | < 0.001 |
Bilirubin (µmol/L); n = 25 | 0–6.8 | 8.00; 4.05–23.40 | 3.20; 2.60–3.80 | < 0.001 |
LDH (U/L); n = 9 | 21–217 | 119.0; 80.5–152.5 | 110.0; 75.5–172.5 | 0.594 |